What does CUSIP 921659108 represent in this 13F holders report?

CUSIP 921659108 is the security identifier for VNDA - Vanda Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VNDA - Vanda Pharmaceuticals Inc. - Common Stock in Q2 2018?

134 institutional investors reported VNDA - Vanda Pharmaceuticals Inc. - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 59,119,327
Total 13F shares: 49,022,523
Share change: +827,405
Total reported value: $933,879,055
Put/Call ratio: 84%
Price per share: $19.05
Number of holders: 134
Value change: +$18,597,031
Number of buys: 69
Number of sells: 54

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 921659108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	7.2%	4,267,002	$71,900,000	—	31 Mar 2018	13F
Palo Alto Investors LP	13F	Company	7%	4,155,670	$70,023,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	5.3%	3,138,560	$52,884,000	—	31 Mar 2018	13F
Consonance Capital Management LP	13F	Company	5.2%	3,072,275	$51,768,000	—	31 Mar 2018	13F
Avoro Capital Advisors LLC	13F	Company	4.7%	2,775,191	$46,762,000	—	31 Mar 2018	13F
ARMISTICE CAPITAL, LLC	13F	Company	4.4%	2,600,000	$43,810,000	—	31 Mar 2018	13F
MACQUARIE GROUP LTD	13F	Company	3.9%	2,278,947	$38,400,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	3.2%	1,884,090	$31,747,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.8%	1,640,050	$27,635,000	—	31 Mar 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.4%	1,400,000	$23,590,000	—	31 Mar 2018	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	2.3%	1,352,576	$22,791,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	2.2%	1,311,471	$22,098,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	2.2%	1,290,636	$21,747,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	2.1%	1,233,256	$20,781,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.7%	996,275	$16,787,000	—	31 Mar 2018	13F
Stonepine Capital Management, LLC	13F	Company	1.7%	984,584	$16,590,000	—	31 Mar 2018	13F
Cormorant Asset Management, LP	13F	Company	1.6%	957,821	$16,139,000	—	31 Mar 2018	13F
PRUDENTIAL FINANCIAL INC	13F	Company	1.4%	847,779	$14,285,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	1.2%	710,928	$11,979,000	—	31 Mar 2018	13F
BAKER BROS. ADVISORS LP	13F	Company	1%	600,354	$10,116,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.99%	584,761	$9,853,000	—	31 Mar 2018	13F
Man Group plc	13F	Company	0.87%	516,600	$8,705,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.87%	516,082	$8,696,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.85%	501,146	$8,443,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.65%	382,137	$6,440,000	—	31 Mar 2018	13F
GREAT POINT PARTNERS LLC	13F	Company	0.52%	309,800	$5,220,000	—	31 Mar 2018	13F
QS Investors, LLC	13F	Company	0.51%	302,610	$5,099,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.49%	289,469	$4,877,000	—	31 Mar 2018	13F
Cortina Asset Management, LLC	13F	Company	0.48%	281,742	$4,747,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.47%	277,016	$4,668,000	—	31 Mar 2018	13F
SEI INVESTMENTS CO	13F	Company	0.45%	263,959	$4,448,000	—	31 Mar 2018	13F
Spark Investment Management LLC	13F	Company	0.44%	262,200	$4,418,000	—	31 Mar 2018	13F
HAWK RIDGE CAPITAL MANAGEMENT LP	13F	Company	0.44%	258,877	$4,362,000	—	31 Mar 2018	13F
AJO, LP	13F	Company	0.43%	254,630	$4,291,000	—	31 Mar 2018	13F
Monashee Investment Management LLC	13F	Company	0.42%	250,000	$4,213,000	—	31 Mar 2018	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.39%	231,731	$3,905,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.39%	229,813	$3,872,000	—	31 Mar 2018	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.38%	226,168	$3,812,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.35%	204,573	$3,447,000	—	31 Mar 2018	13F
J. Goldman & Co LP	13F	Company	0.34%	202,648	$3,415,000	—	31 Mar 2018	13F
Laurion Capital Management LP	13F	Company	0.33%	194,070	$3,270,000	—	31 Mar 2018	13F
Alambic Investment Management, L.P.	13F	Company	0.31%	184,900	$3,116,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.31%	183,896	$3,098,000	—	31 Mar 2018	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.3%	174,437	$2,939,000	—	31 Mar 2018	13F
University Of Notre Dame du Lac	13F	Individual	0.29%	170,834	$2,879,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.28%	163,275	$2,751,000	—	31 Mar 2018	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.23%	137,500	$2,317,000	—	31 Mar 2018	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.23%	137,280	$2,313,000	—	31 Mar 2018	13F
Allianz Asset Management GmbH	13F	Company	0.23%	136,218	$2,295,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.2%	120,424	$2,029,000	—	31 Mar 2018	13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2018

As of 30 Jun 2018, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,022,523 shares. The largest 10 holders included BlackRock Inc., Consonance Capital Management LP, Palo Alto Investors LP, VANGUARD GROUP INC, venBio Select Advisor LLC, MACQUARIE GROUP LTD, ARMISTICE CAPITAL, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 134 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

130

Q2 2018 holders

134

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.